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Introduction
Atrial fibrillation (AF) affects 33.5 million people globally. In the 
United States (US) alone an estimated 3 to 6 million individuals 
have AF with prevalence projected to double by 2050.[1-3] The life-
time risk of developing AF is 1 in 3 among whites and 1 in 5 among 
African Americans, [4,5] and is associated with increased morbidity 
and mortality with a 5-fold increased risk of stroke and substantially 
increased risk of systemic thromboembolism.[6] It is also associated 
with increased risk of dementia,[7] physical disability,[8] heart fail-
ure,[9] myocardial infarction[10] and sudden cardiac death.[11] AF thus 
constitutes a sizeable and growing public health problem, with total 
health-related annual expenses estimated at $6.65 billion and pro-
jected to rise. [12],[13]
   The American Heart Association’s (AHA) impact goal is to im-
prove the cardiovascular health (CVH) of all Americans by 20% by 
2020, while reducing deaths from CVD and stroke by 20%. To help 
achieve this goal of primary prevention of CVD and ideal cardiovas-
cular health, the AHA identified seven modifiable factors, also called 
Life’s Simple 7 (LS7). It consists of 3 health factors (cholesterol level, 
blood pressure, and blood glucose) and 4 behavioral factors (cigarette 
smoking, physical activity, diet, and body mass index (BMI)). An 
overall LS7 score ranges 0 to 14 and is calculated as the sum of the 
LS7 component scores (2 points for ideal, 1 point for intermediate, 
and 0 for poor).[14] This CV health metric has been previously shown 
to predict CVD and heart failure. Recent data suggests reduced risk 
of AF with favorable LS7 score. [15,16] We review the current literature 
on the potential role of individual LS7 components in AF preven-
tion.
Hypertension
Hypertension is a strong independent predictor of AF. [17-19] High 
BP promotes left ventricular diastolic dysfunction, left atrial (LA) 
dilation, cardiac fibrosis and dilation of pulmonary veins, which in 
turn shortens refractoriness and increases risk of AF. [20] Higher pulse 
pressure is a better predictor of AF than systolic or diastolic BP 
alone. Higher systolic blood pressures are associated with higher AF 
risk, whereas diastolic BP was inversely related with AF incidence.[21]
[17][22] This suggests increased pulse pressure associated with vascular 
aging may be a factor related to increased AF incidence in the elderly.
As part of the ARREST AF (Aggressive Risk Factor Reduction 
Study for Atrial Fibrillation and Implications for the Outcome of 
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shown mixed results. This may be due to confounding factors such as 
the timing of treatment onset, and existing irreversible LA structural 
changes. [26] Thus, existing evidence suggest a beneficial effect of BP 
control, specifically lowering systolic BP, as maybe an important 
factor in AF prevention.
Diabetes Mellitus
Optimal, ideal blood glucose is a component of LS7. Diabetes 
Mellitus (DM) is a well-established risk factor for AF[27].It is 
estimated that DM explains 2.5 % of the AF burden[28] .Mechanisms 
linking DM to an increased risk of AF remain speculative. It is 
suggested that cardiac autonomic neuropathy leads to impaired 
parasympathetic tone and this dysfunctional cardiac autonomic 
activity then leads to propagation of AF[29] .
In the Valsartan Antihypertensive Long-term Use Evaluation 
(VALUE) trial, 5250 patients of 15,245 hypertensive patients had 
DM at baseline. Over 4.2 year follow-up 551 patients developed new-
onset AF and 1298 of the initially non-diabetic patients developed 
DM. Investigators demonstrated that patients with new-onset DM 
had a significantly higher rate of new-onset AF with a hazard ratio 
of 1.49 (1.14 to 1.94, p = 0.003) compared to patients without DM. 
[30] Dublin et al. showed that the risk of developing AF was higher 
with longer duration of treated diabetes and worse glycemic control, 
specifically for every 1% increase in HbA1c, a 14% increased risk for 
incident AF was observed[31] .
There is conflicting data based upon the Action to Control 
Cardiovascular Risk in Diabetes (ACCORD) trial in which 10,082 
patients with diabetes were randomized into intensive vs. standard 
glycemic control groups. Targeting a glycated hemoglobin level of 
<6.0% (intensive group) did not affect the rate of new-onset AF. 
However, given the study was focused on intensive and standard 
glycemic control strategies, conclusion regarding the incidence of 
AF in patients with poor glycemic control cannot be obtained. [32] 
In a meta-analysis by Huxley et al. involving 108,703 cases of AF 
in 1,686,097 subjects, it was found that patients with DM had an 
approximate 40% greater risk of AF compared to unaffected patients. 
After taking confounders into account, the subsequent risk of AF 
may be closer to 25% rather than 40% as indicated by the overall 
summary estimate. 28 Given the inconsistencies in these results, 
there is a need for more randomized controlled trials or observational 
studies to look at management strategy for diabetes that would be 
Ablation) study, strict blood pressure control among other aggressive 
risk factor modification (RFM) strategies significantly reduced AF 
recurrence.[23] In high-risk patients, primary prevention of AF via 
renin-angiotensin-aldosterone system (RAAS) inhibition has shown 
promise. A meta-analysis by Healey et. al suggested that the use 
of angiotensin-converting enzyme inhibitors/angiotensin receptor 
blockers (ACEI/ARBs) in patients with left ventricular (LV) 
hypertrophy or LV dysfunction can prevent 20%–30% of new-onset 
AF.[24] Angiotensin II increases sympathetic nervous system activity, 
oxidant production, atrial inflammation and fibrosis, all of which 
could increase risk of AF. This is further supported by the effectiveness 
of ACEI/ARBs in preventing AF over beta blockers and diuretics 
in patients without structural heart disease. [25] Assessment of the 
effectiveness of RAAS inhibition for preventing recurrent AF has 
favorable for AF prevention.
Hypercholesterolemia
Optimal or ideal cholesterol levels are a component of LS7. The 
literature on the role of blood lipid levels, especially total cholesterol, 
and AF risk is inconsistent, and the precise role of total cholesterol in 
the development of AF, if any, remains to be determined.
Potential pathophysiologic mechanisms by which high density 
lipoprotein cholesterol (HDL-C) can prevent AF could be its direct 
anti-inflammatory and antioxidant properties [33]. In addition it may 
be though indirect effects by preventing coronary heart disease and 
heart failure[34] .Elevated triglycerides are associated with metabolic 
syndrome which has been associated with increased AF incidence[35].
In an analysis of the Multi-Ethnic Study of Atherosclerosis 
(MESA) and the Framingham Heart Study (FSH) cohorts in a 
fully adjusted model, including BMI, HDL-C was associated with 
reduced risk of AF (HR 0.89, CI 0.80 to 0.99) and high triglycerides 
were associated with higher risk of AF (HR 1.16, CI 1.06 to 1.27), 
whereas level of low density lipoprotein cholesterol (LDL-C) and 
total cholesterol did not have effect on AF risk (HR 1.04, CI 0.94 to 
1.15 and HR 1.05, CI 0.96 to 1.15 respectively)[36]. In contrast, the 
Atherosclerosis Risk in Communities study (ARIC) study reported 
that high LDL-C and total cholesterol are associated with a lower risk 
of AF, whereas HDL-C and triglycerides were not related to AF risk. 
[37] Similarly, the Cardiovascular Health Study also found lower risk 
of AF among subjects with higher total cholesterol[38]. Inconsistent 
results are likely due to impact of comorbid conditions and lack of 
adjustment of those factors in addition to difference in demographics. 
The role of lipid lowering with statins in AF prevention is unclear, 
with observational studies suggesting reduced AF risk and clinical 
trials failing to do so[39] .For now, there is insufficient evidence to 
support targeting specific lipid-related measures for AF prevention.
Obesity
Obesity is a major public health problem with increasing prevalence 
in the US and is an important, potentially modifiable risk factor for 
AF[40][41]. Several studies have shown adiposity measures other than 
body mass index (BMI) to be associated with increased AF such as 
waist circumference,[42] bioelectrical impedance derived measures 
of body composition and body fat distribution43]. In a longitudinal 
cohort study, BMI also independently predicted the progression 
to permanent AF.[44] The pathophysiology linking obesity to AF is 
multifactorial. Animal models have shown that sustained obesity 
leads to the development of a global electrophysiological and 
structural substrate for AF[45]. Pericardial fat is highly associated with 
paroxysmal and persistent AF independent of traditional risk factors 
including left atrial enlargement[46] .It is also associated with worse 
outcomes after AF ablation. The pericardial adipose tissue is highly 
metabolically active and has been linked to the increased local release 
of various pro-inflammatory mediators, such as interleukin-6 and 
tumor necrosis factor-α, which may promote the activation of ectopic 
foci in the pulmonary vein ostium contributing to AF[47].A recent 
study has shown favorable structural remodeling and a reduction 
in a pericardial adipose tissue after weight loss.[48]  Increased left 
atrial (LA) size is also associated with obesity. [49] An analysis of 
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Arrhythmia Recurrence in Obese Individuals with Atrial Fibrillation) 
study, patients who had high cardiorespiratory fitness had less AF. 
Patients who improved their fitness level by >2 metabolic equivalents 
(METs) had a 2-fold higher probability of AF-free survival, as 
well as lower AF. However, Khan and colleagues found a nonlinear 
relationship between the higher level of cardiopulmonary fitness and 
AF. Given inconsistency in the available literature, a recent meta-
analysis by Zhu et al. looked at the association of physical fitness and 
AF among 205,094 subjects pooled from 6 studies. Per incremental 
increase in physical fitness, a 9% reduction in the risk of AF was seen. 
When physical fitness was assessed, the risk of AF was highest in 
individuals with the lowest level of physical fitness. [64]
Overall, physical activity may have a U-shaped relationship 
with the risk of AF in athletes and non-athletes, and a non-linear 
relationship is observed between physical fitness and the risk of AF. 
However, studies have consistently shown benefit or no harm of 
light-moderate exercise or fitness at the general population level for 
the Framingham cohort showed a stepwise increase in risk for AF 
with ascending quartiles of LA size. It has been suggested that LA 
dilatation is associated with structural and functional atrial tissue 
alterations that facilitate the disturbed impulse propagation of AF.[50]
Several trials have evaluated the impact of weight loss on AF and 
explored the sustainability of weight loss effects, in addition to a 
potential dose-response relationship. In the LEGACY (Long-Term 
Effect of Goal-Directed Weight Management on Atrial Fibrillation 
Cohort) prospective cohort, subjects with >10% weight loss had a 
66-fold greater probability of arrhythmia-free survival compared to 
those who had <10% weight loss. In addition to AF free state, subjects 
with >3% weight loss had evidence of reverse atrial remodeling, 
specifically left atrial volume indexed for body surface area decreased 
significantly.[51] In a recently published study of 4021 obese subjects, 
bariatric surgery was associated with significantly reduced risk of AF 
(hazard ratio: 0.69; 95% confidence interval: 0.58 to 0.82; p < 0.001). 
Of note, this effect was found with significant obesity at baseline: 
men with BMI ≥34 kg/m2 and women with BMI ≥38 kg/m2. [52] 
However, an analysis of The Action for Health in Diabetes (Look 
AHEAD) trial did not find an effect of weight loss on AF incidence. 
Notably, the weight loss achieved in Look AHEAD was less than 
that reported in the bariatric surgery study, thus it may be that only 
more extreme weight loss reduces the risk of AF. [53]
Although obstructive sleep apnea (OSA) is not component of 
LS7, obesity is strongly associated with this disorder [54], OSA is an 
independent risk factor for AF. [55] In the large cross-sectional Sleep 
Heart Health study looking at the prevalence of cardiac arrhythmias 
in patients with OSA, AF rate was 4.8% compared to 0.9% in subjects 
without OSA [56].
There is a clear epidemiological association between obesity and 
AF. There is also substantial evidence that weight control may reduce 
the increasing incidence of AF, making it an important component 
for the primary prevention of AF.
Fitness or Physical Activity
The association between physical activity or fitness and AF is 
complex. It is important to account for pathophysiologic differences 
between cardiorespiratory fitness in the general population in 
comparison to high-intensity physical activity among elite athletes.
[57] Studies that found increased risk of AF with vigorous physical 
activity mainly included subjects with moderate to high exercise level 
such as professional cyclists[58] and endurance athletes[59] among 
others. In contrast, the population-based Cardiovascular Health 
Study of 5446 subjects showed that light to moderate physical 
activity was associated with significantly lower AF incidence in older 
adults and high-intensity exercise did not have an effect. [60] However, 
another population-based (n=38,000) study of light to moderate 
exercise showed no effect on AF. [61] Studies looking specifically at 
fitness level and AF have consistently shown protective effects of 
fitness. Faselis et al. found high levels of fitness was associated with 
reduced risk of AF (odds ratio, 0.37 p<0.001). [62] Similarly, two other 
studies found reduced risk of AF with increasing level of fitness.[63] 
Pathak et al showed that among 308 obese (BMI >27) subjects in 
the CARDIO-FIT (Impact of CARDIOrespiratory FITness on 
AF prevention.
Dietary Patterns
There is paucity of data on the effect of dietary patterns and 
development of AF. Most studies are small and include non-
homogenous populations. PREDIMED (Prevención con Dieta 
Mediterránea) trial is the only interventional study evaluating the 
impact of dietary patterns on AF risk. It enrolled 6705 subjects in 
Spain, who were randomized into three groups (Mediterranean diet 
enriched with extra virgin olive oil(EVOO), or mixed nuts or control 
group). The former intervention reduced AF risk compared with 
control group; (Hazard Ratio 0.62, 95% confidence interval 0.45–
0.85) however, there was no effect in the group with mixed nuts. [65] 
There are no specifics on the quantity of EVOO being consumed, 
which makes it difficult to reach a feasible conclusion. As well, it 
is unclear to what degree EVOO was consumed in the control and 
mixed nuts groups. Data from the Framingham Heart Study found no 
association between caffeine, fiber, and fish-derived polyunsaturated 
fatty acids with AF risk. [66] Alcohol intake, both “binge” drinking 
and moderate consumption 67is a risk factor for AF.[68] The Women’s 
Health Study showed that consumption of even 2 drinks/day was 
associated with risk of AF.[69] The mechanism is thought to be direct 
toxic effect on the cardiomyocytes, altered atrial conduction, short 
refractory period and altered autonomic balance with sympathetic 
predominance. [70,71] In ARREST AF trial, reduction in alcohol use 
contributed to improved AF ablation outcomes.[23]
Figure 1:
Figure shows individual components of Life’s Simple 7 (LS7) and 
their role in atrial fibrillation (AF) prevention.
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analysis tobacco use and fasting blood glucose level were associated 
with lower AF risk in addition to blood pressure and body weight in 
REGARDS
Conclusions
   There is evidence that most of the components of LS7 are risk factors 
for development of AF and are both preventable and modifiable. 
Presence of shared risk factors for CAD and AF rises question 
whether AF is actually a vascular disease. Interestingly, Weijs, et al. 
found subclinical CAD in high proportion of patients with original 
diagnosis of lone AF. [78] Treatment of HTN, smoking cessation, 
weight loss, regular physical activity, preventing and controlling 
diabetes have been shown to have a potential role in AF prevention, 
while data on lipids and dietary modification is limited. Although 
some individual components of LS7 may not have strong AF risk, 
it is possible that these components are related and improvement in 
one could result in reduction of AF by preventing development of the 
other component or modifying its effect. Thus, by achieving optimal 
cardiovascular health profile, as defined by LS7, it is possible to 
substantially reduce AF risk. Nonetheless, further prospective studies 
are needed to better understand implications of favorable LS7 profile 
In a case-control study of 800 patients, those with AF were found to 
have lower adherence to a Mediterranean diet and lower antioxidant 
intake compared to a control population (odds ratio (OR) 1.9, 95% 
confidence interval (CI) 1.58–2.81). In addition, patients in the 
highest quartile of the Mediterranean Score had higher probability 
of spontaneous conversion of atrial fibrillation to sinus rhythm 
(OR1.9; 95%CI 1.58-2.81).[72] Thus, current data suggests potential 
protective effect of EVOO for AF prevention, however future 
research on the clinical significance of these associations is needed. 
Effect sizes of dietary exposures are modest leading to potential 
residual confounding. Lacking direct evidence, Mediterranean 
dietary pattern with possible EVOO supplementation coupled with 
an emphasis on physical activity, maintenance of a healthy lifestyle 
and weight seem reasonable guidance for AF patients, and for those 
with significant risk of AF.
Smoking
Smoking has been reported to predict AF among racially different 
populations.[73,74] Data from the atherosclerosis risk in communities 
(ARIC) study suggests a dose–response relationship, with the 
highest risk of AF observed in individuals with the greatest cigarette 
pack-years of smoking.[73] Current smoking was more strongly and 
consistently associated with AF compared with former smoking 
status. [75] The results of smoking cessation interventions in AF 
have not been well studied. Smoking cessation was one of the risk 
modification measures of ARREST AF trial which showed the 
reduction of AF incidence. [23] However, despite the absence of 
studies looking at the effect of smoking cessation alone and AF risk, 
available evidence supports smoking cessation to be encouraged 
for prevention of AF and overall cardiovascular health. As other 
recreational substance use is not included in LS7, we briefly mention 
their role in AF. In addition to the well-known association of “binge” 
drinking and AF,[67]even moderate intake of alcohol is a risk factor 
for atrial fibrillation. [68] Caffeine consumption on a regular basis was 
not associated with increased incidence of AF. A meta-analysis of six 
cohorts and one case-control study with 115,993 subjects showed 
13% odds reduction in AF among subjects with regular caffeine 
intake (OR 0.87; 95% CI 0.80 to 0.94; I2=39%). [76] Thus, based on 
existing evidence, recommendations against caffeine intake should 
not be practiced for the purpose of AF prevention.
While, Desai et al. have shown increased risk of arrhythmias, 
including AF in hospitalized marijuana users, no prospective trials 
have been conducted to assess this relationship. [77]
Overall Life’s Simple 7 and Atrial Fibrillation
Two recent studies showed role of favorable LS7 in AF prevention. 
Analysis of Reasons for Geographic and Racial Differences in Stroke 
(REGARDS) study showed 5% reduction of AF risk with 1 point 
improvement in LS7score. Out of individual components only blood 
pressure and body weight were associated with risk of incident AF. 
This study had significant limitation in that AF cases were ascertained 
by self-recall at a single follow up visit, about 10 years after baseline 
one.16 More robust results were seen in ARIC study, where 1 point 
improvement in LS7 score was associated with 17% lower risk of 
AF. Additionally, improvement of individual components of LS7 by 
1 level was associated with 12% lower AF risk. Here, in component 
on AF incidence.
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